{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:39:32Z","timestamp":1790843972262,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the young and middle-aged talent development fund of Shanghai Institute of Technology","award":["No. ZQ2021-23"],"award-info":[{"award-number":["No. ZQ2021-23"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 82070288, 11772198"],"award-info":[{"award-number":["Nos. 82070288, 11772198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science & Technology Department of Sichuan Province","award":["No. 2022YFS0627"],"award-info":[{"award-number":["No. 2022YFS0627"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03080-3","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T12:01:55Z","timestamp":1716638515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response"],"prefix":"10.1007","volume":"316","author":[{"given":"Shanshan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"3080_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-022-02522-0","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Hu D, Liu S (2023) New algorithms based on autophagy-related lncRNAs pairs to predict the prognosis of skin cutaneous melanoma patients. Arch Dermatol Res 9:1\u20136. https:\/\/doi.org\/10.1007\/s00403-022-02522-0","journal-title":"Arch Dermatol Res"},{"key":"3080_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","volume":"100","author":"S Carr","year":"2020","unstructured":"Carr S, Smith C, Wernberg J (2020) Epidemiology and risk factors of melanoma. Surg Clin North Am 100:1\u20132. https:\/\/doi.org\/10.1016\/j.suc.2019.09.005","journal-title":"Surg Clin North Am"},{"key":"3080_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/CMR.0000000000000719","volume":"31","author":"RO Bagge","year":"2021","unstructured":"Bagge RO, Ny L, Ascierto PA, Hodi FS, Larkin J, Robert C, Schachter J, Weber JS, Long GV, Van Akkooi AC (2021) The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials. Melanoma Res 31:181\u2013185. https:\/\/doi.org\/10.1097\/CMR.0000000000000719","journal-title":"Melanoma Res"},{"key":"3080_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jamaoncol.2019.5367","volume":"6","author":"J Duan","year":"2020","unstructured":"Duan J, Cui L, Zhao X, Bai H, Cai S, Wang G, Zhao Z, Zhao J, Chen S, Song J, Qi C (2020) Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 inhibitors in patients with cancer: a systematic review and meta-analysis. JAMA Oncol 6:375\u2013384. https:\/\/doi.org\/10.1001\/jamaoncol.2019.5367","journal-title":"JAMA Oncol"},{"key":"3080_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00403-021-02305-z","volume":"314","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Ashida A, Kiniwa Y, Okuyama R (2022) Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma. Arch Dermatol Res 314:887\u2013895. https:\/\/doi.org\/10.1007\/s00403-021-02305-z","journal-title":"Arch Dermatol Res"},{"key":"3080_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun LU, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, Seja E (2016) Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165:35\u201344. https:\/\/doi.org\/10.1016\/j.cell.2016.02.065","journal-title":"Cell"},{"key":"3080_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ, Hellmann MD (2020) Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37:443\u2013455. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.017","journal-title":"Cancer Cell"},{"key":"3080_CR8","doi-asserted-by":"publisher","first-page":"896194","DOI":"10.3389\/fcell.2022.896194","volume":"10","author":"MR Ruocco","year":"2022","unstructured":"Ruocco MR, Lamberti A, Serrano MJ, Fiume G, Arcucci A (2022) Tumor Microenvironment and Cancer Cell interactions in solid Tumor Growth and Therapy Resistance. Front Cell Dev Biol 10:896194. https:\/\/doi.org\/10.3389\/fcell.2022.896194","journal-title":"Front Cell Dev Biol"},{"key":"3080_CR9","doi-asserted-by":"publisher","first-page":"e137066","DOI":"10.1172\/jci.insight.137066","volume":"5","author":"DM Woods","year":"2020","unstructured":"Woods DM, Laino AS, Winters A, Alexandre J, Freeman D, Rao V, Adavani SS, Weber JS, Chattopadhyay PK (2020) Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes. JCI Insight 5:e137066. https:\/\/doi.org\/10.1172\/jci.insight.137066","journal-title":"JCI Insight"},{"key":"3080_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fonc.2020.00722","volume":"10","author":"A Avagliano","year":"2020","unstructured":"Avagliano A, Fiume G, Pelagalli A, Sanit\u00e0 G, Ruocco MR, Montagnani S, Arcucci A (2020) Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol 10:722. https:\/\/doi.org\/10.3389\/fonc.2020.00722","journal-title":"Front Oncol"},{"key":"3080_CR11","doi-asserted-by":"publisher","first-page":"2105118","DOI":"10.1002\/smll.202105118","volume":"18","author":"Y Hei","year":"2022","unstructured":"Hei Y, Chen Y, Li Q, Mei Z, Pan J, Zhang S, Xiong C, Su X, Wei S (2022) Multifunctional immunoliposomes enhance the Immunotherapeutic effects of PD-L1 antibodies against Melanoma by reprogramming immunosuppressive Tumor Microenvironment. Small 18:2105118. https:\/\/doi.org\/10.1002\/smll.202105118","journal-title":"Small"},{"key":"3080_CR12","doi-asserted-by":"publisher","first-page":"eaai9192","DOI":"10.1126\/scisignal.aai9192","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang J, Lin F, Wan Z, Sun X, Lu Y, Huang J, Wang F, Zeng Y, Chen YH, Shi Y, Zheng W (2018) Profiling the origin, dynamics, and function of traction force in B cell activation. Sci Signal 11:eaai9192. https:\/\/doi.org\/10.1126\/scisignal.aai9192","journal-title":"Sci Signal"},{"key":"3080_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-021-02207-0","volume":"1","author":"D Kuraitis","year":"2022","unstructured":"Kuraitis D, Rosenthal N, Boh E, McBurney E (2022) Macrophages in dermatology: pathogenic roles and targeted therapeutics. Arch Dermatol Res 1:1\u20138. https:\/\/doi.org\/10.1007\/s00403-021-02207-0","journal-title":"Arch Dermatol Res"},{"key":"3080_CR14","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30:R921\u2013R925. https:\/\/doi.org\/10.1016\/j.cub.2020.06.081","journal-title":"Curr Biol"},{"key":"3080_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/IJN.S225807","volume":"15","author":"Y Hei","year":"2020","unstructured":"Hei Y, Teng B, Zeng Z, Zhang S, Li Q, Pan J, Luo Z, Xiong C, Wei S (2020) Multifunctional immunoliposomes combining catalase and PD-L1 antibodies overcome tumor hypoxia and enhance immunotherapeutic effects against melanoma. Int J Nanomed 15:1677\u20131691","journal-title":"Int J Nanomed"},{"key":"3080_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","volume":"59","author":"M Marzagalli","year":"2019","unstructured":"Marzagalli M, Ebelt ND, Manuel ER (2019) Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol 59:236\u2013250. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.002","journal-title":"Semin Cancer Biol"},{"key":"3080_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/jdv.16016","volume":"34","author":"C Bence","year":"2020","unstructured":"Bence C, Hofman V, Chamorey E, Long-Mira E, Lassalle S, Albertini AF, Liolios I, Zahaf K, Picard A, Montaudi\u00e9 H, Lacour JP (2020) Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma. J Eur Acad Dermatol Venereol 34:984\u2013994. https:\/\/doi.org\/10.1111\/jdv.16016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3080_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Da\u00ebron M, Morel Y, Medzhitov R, Vivier E (2019) Harnessing innate immunity in cancer therapy. Nature 574:45\u201356. https:\/\/doi.org\/10.1038\/s41586-019-1593-5","journal-title":"Nature"},{"key":"3080_CR19","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.7150\/ijbs.25720","volume":"14","author":"S Guo","year":"2018","unstructured":"Guo S, Deng CX (2018) Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci 14:2083. https:\/\/doi.org\/10.7150\/ijbs.25720","journal-title":"Int J Biol Sci"},{"key":"3080_CR20","doi-asserted-by":"publisher","unstructured":"Pach E, Brinckmann J, R\u00fcbsam M, K\u00fcmper M, Mauch C, Zigrino P (2021) Fibroblast mmp14-dependent collagen processing is necessary for melanoma growth. Cancers 13:1984. https:\/\/doi.org\/10.3390\/cancers13081984","DOI":"10.3390\/cancers13081984"},{"key":"3080_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","volume":"1060","author":"AE Denton","year":"2018","unstructured":"Denton AE, Roberts EW, Fearon DT (2018) Stromal cells in the Tumor Microenvironment. Adv Exp Med Biol 1060:99\u2013114. https:\/\/doi.org\/10.1007\/978-3-319-78127-3_6","journal-title":"Adv Exp Med Biol"},{"key":"3080_CR22","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.3390\/ijms22105283","volume":"22","author":"V Romano","year":"2021","unstructured":"Romano V, Belviso I, Venuta A, Ruocco MR, Masone S, Aliotta F, Fiume G, Montagnani S, Avagliano A, Arcucci A (2021) Influence of tumor microenvironment and fibroblast population plasticity on melanoma growth, therapy resistance and immunoescape. Int J Mol Sci 22:5283. https:\/\/doi.org\/10.3390\/ijms22105283","journal-title":"Int J Mol Sci"},{"key":"3080_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan Z, Chen X, Zuo J, Fu S, Wang H, Wang J (2023) Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J Transl Med 21:223. https:\/\/doi.org\/10.1186\/s12967-023-04056-z","journal-title":"J Transl Med"},{"key":"3080_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1101\/gr.260174.119","volume":"30","author":"KM Nip","year":"2020","unstructured":"Nip KM, Chiu R, Yang C, Chu J, Mohamadi H, Warren RL, Birol I (2020) RNA-bloom enables reference-free and reference-guided sequence assembly for single-cell transcriptomes. Genome Res 30:1191\u20131200. http:\/\/www.genome.org\/cgi\/doi\/https:\/\/doi.org\/10.1101\/gr.260174.119","journal-title":"Genome Res"},{"key":"3080_CR25","doi-asserted-by":"publisher","first-page":"8624963","DOI":"10.1155\/2020\/8624963","volume":"2020","author":"A No\u00e9","year":"2020","unstructured":"No\u00e9 A, Cargill TN, Nielsen CM, Russell AJ, Barnes E (2020) The application of single-cell RNA sequencing in vaccinology. J Immunol Res 2020:8624963. https:\/\/doi.org\/10.1155\/2020\/8624963","journal-title":"J Immunol Res"},{"key":"3080_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IW, Ng LG, Ginhoux F, Newell EW (2019) Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol 37:38\u201344. https:\/\/doi.org\/10.1038\/nbt.4314","journal-title":"Nat Biotechnol"},{"key":"3080_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, Butte AJ (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profbrotic macrophage. Nat Immunol 20:163\u2013172. https:\/\/doi.org\/10.1038\/s41590-018-0276-y","journal-title":"Nat Immunol"},{"key":"3080_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-1002-1","volume":"37","author":"Y He","year":"2018","unstructured":"He Y, Jiang Y, Chen Z, Wang C X (2018) Classification of triple-negative breast cancers based on immunogenomic profiling. J Exp Clin Cancer Res 37:1\u201313. https:\/\/doi.org\/10.1186\/s13046-018-1002-1","journal-title":"J Exp Clin Cancer Res"},{"key":"3080_CR29","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361. https:\/\/doi.org\/10.1093\/nar\/gkw1092","journal-title":"Nucleic Acids Res"},{"key":"3080_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R (2011) Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Softw 39:1. https:\/\/doi.org\/10.18637\/jss.v039.i05","journal-title":"J Stat Softw"},{"key":"3080_CR31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nat Commun"},{"key":"3080_CR32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/j.apsb.2021.12.005","volume":"12","author":"D Liang","year":"2022","unstructured":"Liang D, Yu C, Ma Z, Yang X, Li Z, Dong X, Qin X, Du L, Li M (2022) Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning. Acta Pharm Sin B 12:2429\u20132442. https:\/\/doi.org\/10.1016\/j.apsb.2021.12.005","journal-title":"Acta Pharm Sin B"},{"key":"3080_CR33","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1158\/0008-5472.CAN-17-0327","volume":"77","author":"S Mei","year":"2017","unstructured":"Mei S, Meyer CA, Zheng R, Qin Q, Wu Q, Jiang P, Li B, Shi X, Wang B, Fan J, Shih C (2017) Cistrome cancer: a web resource for integrative gene regulation modeling in cancer. Cancer Res 77:e19\u2013e22. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0327","journal-title":"Cancer Res"},{"key":"3080_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92\u2013105. https:\/\/doi.org\/10.1111\/j.0006-341X.2005.030814.x","journal-title":"Biometrics"},{"key":"3080_CR35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21:938\u2013945. https:\/\/doi.org\/10.1038\/nm.3909","journal-title":"Nat Med"},{"key":"3080_CR36","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, Albright A, Cheng JD, Kang SP, Shankaran V, Piha-Paul SA (2017) IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade. J Clin Investig 127:2930\u20132940. https:\/\/doi.org\/10.1172\/JCI91190","journal-title":"J Clin Investig"},{"key":"3080_CR37","doi-asserted-by":"publisher","first-page":"585980","DOI":"10.3389\/fonc.2020.585980","volume":"10","author":"Q Wan","year":"2020","unstructured":"Wan Q, Liu C, Liu C, Liu W, Wang X, Wang Z (2020) Discovery and validation of a metastasis-related prognostic and diagnostic biomarker for melanoma based on single cell and gene expression datasets. Front Oncol 10:585980. https:\/\/doi.org\/10.3389\/fonc.2020.585980","journal-title":"Front Oncol"},{"key":"3080_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S (2018) A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175:984\u2013997. https:\/\/doi.org\/10.1016\/j.cell.2018.09.006","journal-title":"Cell"},{"key":"3080_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/exd.12002","volume":"21","author":"G Reichenbach","year":"2012","unstructured":"Reichenbach G, Starzinski-Powitz A, Doll M, Hrgovic I, Maria Valesky E, Kippenberger S, Bernd A, Kaufmann R, Meissner M (2012) Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner. Exp Dermatol 21:751\u2013757. https:\/\/doi.org\/10.1111\/exd.12002","journal-title":"Exp Dermatol"},{"key":"3080_CR40","doi-asserted-by":"publisher","first-page":"989167","DOI":"10.3389\/fonc.2022.989167","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xu X, Xu R, Ye T (2022) Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis. Front Oncol 12:989167. https:\/\/doi.org\/10.3389\/fonc.2022.989167","journal-title":"Front Oncol"},{"key":"3080_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1593\/neo.11426","volume":"14","author":"T Aschacher","year":"2012","unstructured":"Aschacher T, Sampl S, K\u00e4ser L, Bernhard D, Spittler A, Holzmann K, Bergmann M (2012) The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations. Neoplasia 14:44\u201353. https:\/\/doi.org\/10.1593\/neo.11426","journal-title":"Neoplasia"},{"key":"3080_CR42","doi-asserted-by":"publisher","unstructured":"Li Y, Li Y, Liu Q, Wang A (2015) Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells. OncoTargets Ther 2015:1043\u20131051. https:\/\/doi.org\/10.2147\/OTT.S70691","DOI":"10.2147\/OTT.S70691"},{"key":"3080_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-021-09667-0","volume":"2021","author":"A Barzegar-Fallah","year":"2021","unstructured":"Barzegar-Fallah A, Alimoradi H, Dunlop JL, Torbati E, Baird SK (2021) Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-\u03ba B downregulation. Cell Biol Toxicol 2021:1\u201317. https:\/\/doi.org\/10.1007\/s10565-021-09667-0","journal-title":"Cell Biol Toxicol"},{"key":"3080_CR44","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.18632\/oncotarget.23455","volume":"9","author":"AL Isola","year":"2018","unstructured":"Isola AL, Eddy K, Zembrzuski K, Goydos JS, Chen S (2018) Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness. Oncotarget 9:1187. https:\/\/doi.org\/10.18632\/oncotarget.23455","journal-title":"Oncotarget"},{"key":"3080_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fimmu.2016.00024","volume":"7","author":"J Brzostek","year":"2016","unstructured":"Brzostek J, Gascoigne NR, Rybakin V (2016) Cell type-specific regulation of immunological synapse dynamics by B7 ligand recognition. Front Immunol 7:24. https:\/\/doi.org\/10.3389\/fimmu.2016.00024","journal-title":"Front Immunol"},{"key":"3080_CR46","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41590-022-01289-w","volume":"23","author":"A Kennedy","year":"2022","unstructured":"Kennedy A, Waters E, Rowshanravan B, Hinze C, Williams C, Janman D, Fox TA, Booth C, Pesenacker AM, Halliday N, Soskic B (2022) Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. Nat Immunol 23:1365\u20131378. https:\/\/doi.org\/10.1038\/s41590-022-01289-w","journal-title":"Nat Immunol"},{"key":"3080_CR47","doi-asserted-by":"publisher","first-page":"14612","DOI":"10.1002\/jcp.28181","volume":"234","author":"Z Payandeh","year":"2019","unstructured":"Payandeh Z, Yarahmadi M, Nariman-Saleh\u2010Fam Z, Tarhriz V, Islami M, Aghdam AM, Eyvazi S (2019) Immune therapy of melanoma: overview of therapeutic vaccines. J Cell Physiol 234:14612\u201314621. https:\/\/doi.org\/10.1002\/jcp.28181","journal-title":"J Cell Physiol"},{"key":"3080_CR48","doi-asserted-by":"publisher","first-page":"654350","DOI":"10.3389\/fonc.2021.654350","volume":"11","author":"H Qiu","year":"2021","unstructured":"Qiu H, Tian W, He Y, Li J, He C, Li Y, Liu N, Li J (2021) Integrated analysis reveals prognostic value and immune correlates of CD86 expression in lower grade glioma. Front Oncol 11:654350. https:\/\/doi.org\/10.3389\/fonc.2021.654350","journal-title":"Front Oncol"},{"key":"3080_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-251","volume":"9","author":"ES Ch\u2019ng","year":"2010","unstructured":"Ch\u2019ng ES, Kumanogoh A (2010) Roles of Sema4D and Plexin-B1 in tumor progression. Mol Cancer 9:1\u20139. https:\/\/doi.org\/10.1186\/1476-4598-9-251","journal-title":"Mol Cancer"},{"key":"3080_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2016.08.001","volume":"29","author":"G Neufeld","year":"2016","unstructured":"Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O (2016) The semaphorins and their receptors as modulators of tumor progression. Drug Resist Updat 29:1\u201312. https:\/\/doi.org\/10.1016\/j.drup.2016.08.001","journal-title":"Drug Resist Updat"},{"key":"3080_CR51","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH (2019) Context-dependent roles of complement in cancer. Nat Rev Cancer 19:698\u2013715. https:\/\/doi.org\/10.1038\/s41568-019-0210-0","journal-title":"Nat Rev Cancer"},{"key":"3080_CR52","doi-asserted-by":"publisher","first-page":"e1009220","DOI":"10.1371\/journal.ppat.1009220","volume":"17","author":"H Feng","year":"2021","unstructured":"Feng H, Zhang YB, Gui JF, Lemon SM, Yamane D (2021) Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses. PLOS Pathog 17:e1009220. https:\/\/doi.org\/10.1371\/journal.ppat.1009220","journal-title":"PLOS Pathog"},{"key":"3080_CR53","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cca.2020.10.030","volume":"511","author":"F Jiang","year":"2020","unstructured":"Jiang F, Wu C, Wang M, Wei K, Zhou G, Wang J (2020) Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma. Clin Chim Acta 511:306\u2013318. https:\/\/doi.org\/10.1016\/j.cca.2020.10.030","journal-title":"Clin Chim Acta"},{"key":"3080_CR54","first-page":"849","volume":"14","author":"Z Wang","year":"2022","unstructured":"Wang Z, Hou H, Zhang H, Duan X, Li L, Meng L (2022) Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma. Am J Transl Res 14:849","journal-title":"Am J Transl Res"},{"key":"3080_CR55","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.18632\/aging.103296","volume":"12","author":"Q Wang","year":"2020","unstructured":"Wang Q, Yang Y, Yang M, Li X, Chen K (2020) High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16\/CA125 mutations. Aging 12:10827. https:\/\/doi.org\/10.18632\/aging.103296","journal-title":"Aging"},{"key":"3080_CR56","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s00262-021-03139-4","volume":"71","author":"J Femel","year":"2022","unstructured":"Femel J, Van Hooren L, Herre M, Cedervall J, Saupe F, Huijbers EJ, Verboogen DR, Reichel M, Thijssen VL, Griffioen AW, Hellman L (2022) Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden. Cancer Immunol Immunother 71:2029\u20132040. https:\/\/doi.org\/10.1007\/s00262-021-03139-4","journal-title":"Cancer Immunol Immunother"},{"key":"3080_CR57","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1080\/21645515.2017.1312043","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Yang L, Wang D, Zhang Q, Zhang L (2017) Pro-tumor activities of macrophages in the progression of melanoma. Hum Vaccin Immunother 13:1556\u20131562. https:\/\/doi.org\/10.1080\/21645515.2017.1312043","journal-title":"Hum Vaccin Immunother"},{"key":"3080_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-022-03302-5","volume":"2022","author":"JS Weber","year":"2022","unstructured":"Weber JS, Poretta T, Stwalley BD, Sakkal LA, Du EX, Wang T, Chen Y, Wang Y, Betts KA, Shoushtari AN (2022) Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival. Cancer Immunol Immunother 2022:1\u201310. https:\/\/doi.org\/10.1007\/s00262-022-03302-5","journal-title":"Cancer Immunol Immunother"},{"key":"3080_CR59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03080-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:35:03Z","timestamp":1719401703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03080-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03080-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"28 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}